Browse > Article
http://dx.doi.org/10.7314/APJCP.2013.14.4.2649

Prevalence of Depression in Breast Cancer Survivors: a Systematic Review of Observational Studies  

Zainal, Nor Zuraida (Psychological Medicine Research Group of University Malaya (PARADIGM), Faculty of Medicine, University of Malaya)
Nik-Jaafar, Nik Ruzyanei (Department of Psychiatry, Universiti Kebangsaan Malaysia Medical Centre)
Baharudin, Azlin (Department of Psychiatry, Universiti Kebangsaan Malaysia Medical Centre)
Sabki, Zuraida Ahmad (Psychological Medicine Research Group of University Malaya (PARADIGM), Faculty of Medicine, University of Malaya)
Ng, Chong Guan (Psychological Medicine Research Group of University Malaya (PARADIGM), Faculty of Medicine, University of Malaya)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.14, no.4, 2013 , pp. 2649-2656 More about this Journal
Abstract
Background: Depression is common in breast cancer patients. The aim of this paper was to make a systematic review of its prevalence and associated factors oin breast cancer survivors. Materials and Methods: An extensive systematic electronic review (PUBMED, CINAHL, PsyINFO and Ovid) and handsearch were carried out to retrieve published articles up to November 2012, using Depression OR Dysthymia AND (Cancer OR Tumor OR Neoplasms as the keywords. Information about the design of the studies, measuring scale, characteristics of the participants, prevalence of depression and its associated factors from the included studies were extracted and summarized. Results: We identified 32 eligible studies that recruited 10,826 breast cancer survivors. Most were cross-sectional or prospective designed. The most frequent instrument used to screen depression was the Center for Epidemiological Studies for Depression (CES-D, n=11 studies) followed by the Beck Depression Inventory (BDI, n=6 studies) and the Hospital Anxiety and Depression Scale (HADS, n=6 studies). CES-D returned about similar prevalence of depression (median=22%, range=13-56%) with BDI (median=22%, range=17-48%) but higher than HADS (median=10%, range=1-22%). Depression was associated with several socio-demographic variables, cancer-related factors, treatment-related factors, subject psychological factors, lifestyle factors, social support and quality of life. Conclusions: Breast cancer survivors are at risk for depression so that detection of associated factors is important in clinical practice.
Keywords
Prevalence; depression; breast; cancer; survivors; risk factors;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Alcalar N, Ozkan S, Kucucuk S, et al (2012). Association of coping style, cognitive errors and cancer-related variables with depression in women treated for breast cancer. Jpn J Clin Oncol, 42, 940-7.   DOI
2 Alexander S, Palmer C, Stone PC (2010). Evaluation of screening instruments for depression and anxiety in breast cancer survivors. Breast Cancer Res Treat, 122, 573-8.   DOI
3 Allen JD, Savadatti S, Levy AG (2009). The transition from breast cancer 'patient' to 'survivor'. Psychooncology, 18, 71-8.   DOI   ScienceOn
4 Azim HA Jr, de Azambuja E, Colozza M, et al (2011). Long-term toxic effects of adjuvant chemotherapy in breast cancer. Ann Oncol, 22, 1939-47   DOI   ScienceOn
5 Begovic-Juhant A, Chmielewski A, Iwuagwu S, et al (2012). Impact of body image on depression and quality of life among women with breast cancer. J Psychosoc Oncol, 30, 446-60.   DOI   ScienceOn
6 Bower JE, Ganz PA, Desmond KA, et al (2000). Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol, 18, 743-53.
7 Bower JE, Ganz PA, Irwin MR, et al (2011). Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism? J Clin Oncol, 29, 3517-22.   DOI   ScienceOn
8 Broeckel JA, Jacobsen PB, Balducci L, et al (2000). Quality of life after adjuvant chemotherapy for breast cancer. Breast Cancer Res Treat, 62, 141-50.   DOI   ScienceOn
9 Carpenter JS, Elam JL, Ridner SH, et al (2004). Sleep, fatigue, and depressive symptoms in breast cancer survivors and matched healthy women experiencing hot flashes. Oncol Nurs Forum, 31, 5591-8.
10 Chen X, Zheng Y, Zheng W, et al (2009). Prevalence of depression and its related factors among Chinese women with breast cancer. Acta Oncol, 48, 1128-36.   DOI   ScienceOn
11 Coleman MP, Forman D, Bryant H, et al (2011). Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet, 377, 127-38   DOI   ScienceOn
12 Den Oudsten BL, Van Heck GL, Van der Steeg AF, et al (2009). Predictors of depressive symptoms 12 months after surgical treatment of early-stage breast cancer. Psychooncology, 18, 1230-7.   DOI   ScienceOn
13 Deshields T, Tibbs T, Fan MY, Taylor M (2006). Differences in patterns of depression after treatment for breast cancer. Psychooncology, 15, 398-406.   DOI   ScienceOn
14 Eversley R, Estrin D, Dibble S, et al (2005). Post-treatment symptoms among ethnic minority breast cancer survivors. Oncol Nurs Forum, 32, 250-6.   DOI
15 Fann JR, Thomas-Rich AM, Katon WJ, et al (2008). Major depression after breast cancer: a review of epidemiology and treatment. Gen Hosp Psychiatry, 30, 112-26.   DOI   ScienceOn
16 Green BL, Rowland JH, Krupnick JL, et al (1998). Prevalence of posttraumatic stress disorder in women with breast cancer. Psychosomatics, 39, 102-11.   DOI   ScienceOn
17 Hann D, Winter K, Jacobsen P (1999). Measurement of depressive symptoms in cancer patients: evaluation of the Center for Epidemiological Studies Depression Scale (CES-D). J Psychosom Res, 46, 437-43.   DOI   ScienceOn
18 Hill J, Holcombe C, Clark L, et al (2011). Predictors of onset of depression and anxiety in the year after diagnosis of breast cancer. Psychol Med, 41, 1429-36.   DOI   ScienceOn
19 Hopwood P, Sumo G, Mills J, et al (2010). The course of anxiety and depression over 5 years of follow-up and risk factors in women with early breast cancer: results from the UK Standardisation of Radiotherapy Trials (START). Breast, 19, 84-91.   DOI   ScienceOn
20 Howard-Anderson J, Ganz PA, Bower JE, Stanton AL (2012). Quality of life, fertility concerns, and behavioral health outcomes in younger breast cancer survivors: a systematic review. J Natl Cancer Inst, 104, 386-405.   DOI
21 Hsiao FH, Chang KJ, Kuo WH, et al (2013). A longitudinal study of cortisol responses, sleep problems, and psychological wellbeing as the predictors of changes in depressive symptoms among breast cancer survivors. Psychoneuroendocrinology, 38, 356-66.   DOI   ScienceOn
22 Inagaki M, Matsuoka Y, Sugahara Y, et al (2004). Hippocampal volume and first major depressive episode after cancer diagnosis in breast cancer survivors. Am J Psychiatry, 161, 2263-70.   DOI   ScienceOn
23 Jang JE, Kim SW, Kim SY, et al (2012). Religiosity, depression, and quality of life in Korean patients with breast cancer: a 1-year prospective longitudinal study. Psychooncology, 22, 922-9.
24 Johnson JL, Minarik PA, Nystrom KV, et al (2006). Poststroke depression incidence and risk factors: an integrative literature review. J Neurosci Nurs, 38, 316-27.   DOI
25 Karakoyun-Celik O, Gorken I, Sahin S, et al (2010). Depression and anxiety levels in woman under follow-up for breast cancer: relationship to coping with cancer and quality of life. Med Oncol, 27, 108-13.   DOI   ScienceOn
26 Khan F, Amatya B, Pallant JF, Rajapaksa I (2012). Factors associated with long-term functional outcomes and psychological sequelae in women after breast cancer. Breast, 21, 314-20.   DOI   ScienceOn
27 Lorizio W, Wu AH, Beattie MS, et al (2012). Clinical and biomarker predictors of side effects from tamoxifen. Breast Cancer Res Treat, 132, 1107-18   DOI
28 Makambi KH, Williams CD, Taylor TR, et al (2009). An assessment of the CES-D scale factor structure in black women: The Black Women's Health Study. Psychiatry Res, 168, 163-70.   DOI   ScienceOn
29 Mitchell AJ, Lord K, Symonds P (2012). Which symptoms are indicative of DSMIV depression in cancer settings? An analysis of the diagnostic significance of somatic and nonsomatic symptoms. J Affect Disord, 138, 137-48.   DOI   ScienceOn
30 Mehnert A, Koch U (2008). Psychological comorbidity and health-related quality of life and its association with awareness, utilization, and need for psychosocial support in a cancer register-based sample of long-term breast cancer survivors. J Psychosom Res, 64, 383-91.   DOI   ScienceOn
31 Mitchell AJ, Meader N, Symonds P (2010). Diagnostic validity of the Hospital Anxiety and Depression Scale (HADS) in cancer and palliative settings: a meta-analysis. J Affect Disord, 126, 335-48.   DOI   ScienceOn
32 Moher D, Liberati A, Tetzlaff J, Altman DG (2009). Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ, 339, 2535.   DOI   ScienceOn
33 Morrill EF, Brewer NT, O'Neill SC, et al (2008). The interaction of post-traumatic growth and post-traumatic stress symptoms in predicting depressive symptoms and quality of life. Psychooncology, 17, 948-53.   DOI   ScienceOn
34 Ng CG, Boks MP, Zainal NZ, de Wit NJ (2011). The prevalence and pharmacotherapy of depression in cancer patients. J Affect Disord, 131, 1-7.   DOI   ScienceOn
35 Odle TG (2011). Breast cancer survivorship and surveillance. Radiol Technol, 83, 63-87.
36 Park BW, Hwang SY (2012). Unmet needs of breast cancer patients relative to survival duration. Yonsei Med J, 53, 118-25.   DOI   ScienceOn
37 Pan L, Han Y, Sun X, et al (2010). FDG-PET and other imaging modalities for the evaluation of breast cancer recurrence and metastases: a meta-analysis. J Cancer Res Clin Oncol, 136, 1007-22.   DOI
38 Pumo V, Milone G, Iacono M, et al (2012). Psychological and sexual disorders in long-term breast cancer survivors. Cancer Manag Res, 4, 61-5.
39 Phillips KA, Osborne RH, Giles GG, et al (2008). Psychosocial factors and survival of young women with breast cancer: a population-based prospective cohort study. J Clin Oncol, 26, 4666-71.   DOI   ScienceOn
40 Popoola AO, Adewuya AO (2012). Prevalence and correlates of depressive disorders in outpatients with breast cancer in Lagos, Nigeria. Psychooncology, 21, 675-9.   DOI   ScienceOn
41 Qiu J, Yang M, Chen W et al (2012). Prevalence and correlates of major depressive disorder in breast cancer survivors in Shanghai, China. Psychooncology, 21, 1331-7.   DOI   ScienceOn
42 Rabin EG, Heldt E, Hirakata VN, et al (2009). Depression and perceptions of quality of life of breast cancer survivors and their male partners. Oncol Nurs Forum, 36, 153-8.   DOI   ScienceOn
43 Schou I, Ekeberg O, Ruland CM, et al (2004). Pessimism as a predictor of emotional morbidity one year following breast cancer surgery. Psychooncology, 13, 309-20.   DOI   ScienceOn
44 Schreiber JA (2011). Image of God: effect on coping and psychospiritual outcomes in early breast cancer survivors. Oncol Nurs Forum, 38, 293-301.   DOI   ScienceOn
45 Speer JJ, Hillenberg B, Sugrue DP, et al (2005). Study of sexual functioning determinants in breast cancer survivors. Breast J, 11, 440-7.   DOI   ScienceOn
46 Tangney CC, Young JA, Murtaugh MA, et al (2002). Selfreported dietary habits, overall dietary quality and symptomatology of breast cancer survivors: a cross-sectional examination. Breast Cancer Res Treat, 71, 113-23.   DOI   ScienceOn
47 Ullrich PM, Rothrock NE, Lutgendorf SK, et al J (2008). Adjustment and discussion of cancer: A comparison of breast and prostate cancer survivors. Psychol Health, 23, 391-406.   DOI   ScienceOn
48 Wang GL, Hsu SH, Feng AC, et al (2011). The HADS and the DT for screening psychosocial distress of cancer patients in Taiwan. Psychooncology, 20, 639-46.   DOI   ScienceOn
49 Vahdaninia M, Omidvari S, Montazeri A (2010). What do predict anxiety and depression in breast cancer patients? A followup study. Soc Psychiatry Psychiatr Epidemiol, 45, 355-61.   DOI
50 Van Wilgen CP, Dijkstra PU, Stewart RE, et al (2006). Measuring somatic symptoms with the CES-D to assess depression in cancer patients after treatment: comparison among patients with oral/oropharyngeal, gynecological, colorectal, and breast cancer. Psychosomatics, 47, 465-70.   DOI   ScienceOn
51 Warmenhove F, Van Rijswijk E, Engels Y, et al (2012). The Beck Depression Inventory (BDI-II) and a single screening question as screening tools for depressive disorder in Dutch advanced cancer patients. Support Care Cancer, 20, 319-24.   DOI
52 Watson M, Haviland JS, Greer S, et al (1999). Influence of psychological response on survival in breast cancer: a population-based cohort study. Lancet, 354, 1331-6.   DOI   ScienceOn
53 Weinberger T, Forrester A, Markov D, et al (2010). Women at a dangerous intersection: diagnosis and treatment of depression and related disorders in patients with breast cancer. Psychiatr Clin North America, 33, 409-22.   DOI   ScienceOn
54 Zainal NZ, Booth S, Huppert FA (2012). The efficacy of mindfulness-based stress reduction on mental health of breast cancer patients: a meta-analysis. Psychooncology, [Epub ahead of print].